Planet 13 Holdings (PLNH) Assets Average (2022 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Assets Average of $149.6 million for Q1 2026, down 27.12% year-over-year from $205.3 million in Q1 2025, and down 3.73% quarter-over-quarter from $155.4 million in Q4 2025.
Planet 13 Holdings (PLNH) Assets Average (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Assets Average for 5 consecutive years, with $149.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 27.12% year-over-year to $149.6 million; the TTM figure through Mar 2026 stood at $149.6 million (down 27.12% YoY), while the FY2025 annual figure was $179.5 million, changed 0.15% from the prior year.
- Assets Average fell to $149.6 million in Q1 2026 per PLNH's latest filing, from $155.4 million in the prior quarter.
- Across five years, Assets Average topped out at $271.2 million in Q2 2022 and bottomed at $149.6 million in Q1 2026.
- Historically, Assets Average has averaged $206.1 million across 5 years, with a median of $205.3 million in 2025.
- Annual changes were most pronounced in 2023 — Assets Average slumped 35.09% — and 2024, when it surged 43.29%.
- Planet 13 Holdings' Assets Average stood at $241.7 million in 2022, then tumbled by 35.09% to $156.9 million in 2023, then soared by 43.29% to $224.8 million in 2024, then tumbled by 30.89% to $155.4 million in 2025, then declined by 3.73% to $149.6 million in 2026.
- Business Quant data shows PLNH's Assets Average at $149.6 million in Q1 2026, $155.4 million in Q4 2025, and $179.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn | 145.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145.60 Mn |
| Mar 31, 2026 | 149.60 Mn |
| Dec 31, 2025 | 155.39 Mn |
| Sep 30, 2025 | 179.74 Mn |
| Jun 30, 2025 | 202.38 Mn |
| Mar 31, 2025 | 205.26 Mn |
| Dec 31, 2024 | 224.85 Mn |
| Sep 30, 2024 | 242.70 Mn |
| Jun 30, 2024 | 199.91 Mn |
| Mar 31, 2024 | 154.57 Mn |
| Dec 31, 2023 | 156.92 Mn |
| Sep 30, 2023 | 184.40 Mn |
| Jun 30, 2023 | 209.09 Mn |
| Mar 31, 2023 | 215.77 Mn |
| Dec 31, 2022 | 241.74 Mn |
| Sep 30, 2022 | 265.93 Mn |
| Jun 30, 2022 | 271.22 Mn |
| Mar 31, 2022 | 243.90 Mn |